IPOs Keep Blasting Past Pricing Expectations

  • Investing.com
  • Stock Market News
IPOs Keep Blasting Past Pricing Expectations
Credit: © Reuters.

By Christiana Sciaudone

Investing.com -- Initial public offerings keep surprising.

Curevac Bv (NASDAQ: CVAC ), a German biopharmaceutical company working on a coronavirus vaccine, opened Friday at $44 after pricing at $16. Meanwhile, fintech insurer Duck Creek Technologies Inc (NASDAQ: DCT ) opened at $42 after pricing at $27.

They are the latest companies to blast through pricing in their first day of trading. Last month, insurance start-up Lemonade Inc (NYSE: LMND ) saw shares jump as much as 144% upon going public. Also in July, Bigcommerce Holdings Inc (NASDAQ: BIGC ) rose 292% on its opening.

Trying to price an IPO isn't easy, Santosh Rao, head of research at Manhattan Venture Partners, told Marketplace last year. “Pricing, in general, at a very high level, is more an art than science,” said Rao.

CureVac has been backed by the Bill & Melinda Gates Foundation in the past. It is focused on using messenger RNA to treat diseases. The company raised more than $213 million in its IPO.

Duck Creek's $405 million IPO was oversubscribed, according to IPO Boutique. The company provides a software-as-a-service platform, or SaaS, for the property and casualty insurance industry.

Among its 150 customers are Progressive (NYSE: PGR ), Liberty Mutual, AIG (NYSE: AIG ) and Geico.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or